Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon-Luke L Seagle

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|March 21, 2017
Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database studyBrandon-Luke L Seagle, Janelle Sobecki-Rausch, Anna E Strohl, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 10, 2014
Feasibility, Sensitivity, and Specificity of Postprocedure Peritoneal CytologyBrandon-Luke L Seagle, Melissa Dawson, Robert Samuelson, et al.
JCO Clinical Cancer Informatics|September 4, 2018
Association of Lymph Node Count and Overall Survival in Node-Negative Endometrial CancersBrandon-Luke L Seagle, Douglas Gilchrist-Scott, Stephen Graves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast CancerChelain R Goodman, Brandon-Luke L Seagle, Masha Kocherginsky, et al.
Journal of the American Chemical Society|August 11, 2005
Time-resolved detection of melanin free radicals quenching reactive oxygen speciesBrandon-Luke L Seagle, Kourous A Rezai, Elzbieta M Gasyna, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2005
Melanin photoprotection in the human retinal pigment epithelium and its correlation with light-induced cell apoptosisBrandon-Luke L Seagle, Kourous A Rezai, Yasuhiro Kobori, et al.
Connecticut Medicine|September 9, 2014
Genetic counseling for hereditary breast and gynecologic cancer syndromes at a community hospitalKarina M Haber, Brandon-Luke L Seagle, Barbara Drew, et al.
Scientific Reports|February 18, 2016
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancerBrandon-Luke L Seagle, Kevin H Eng, Judy Y Yeh, et al.
Gynecologic Oncology|January 21, 2019
Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancerChelain R Goodman, Saleh Hatoum, Brandon-Luke L Seagle, et al.
Gynecologic Oncology|May 11, 2015
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome AtlasBrandon-Luke L Seagle, Chia-Ping Huang Yang, Kevin H Eng, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|March 21, 2017
Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database studyBrandon-Luke L Seagle, Janelle Sobecki-Rausch, Anna E Strohl, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|December 10, 2014
Feasibility, Sensitivity, and Specificity of Postprocedure Peritoneal CytologyBrandon-Luke L Seagle, Melissa Dawson, Robert Samuelson, et al.
JCO Clinical Cancer Informatics|September 4, 2018
Association of Lymph Node Count and Overall Survival in Node-Negative Endometrial CancersBrandon-Luke L Seagle, Douglas Gilchrist-Scott, Stephen Graves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2018
21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast CancerChelain R Goodman, Brandon-Luke L Seagle, Masha Kocherginsky, et al.
Journal of the American Chemical Society|August 11, 2005
Time-resolved detection of melanin free radicals quenching reactive oxygen speciesBrandon-Luke L Seagle, Kourous A Rezai, Elzbieta M Gasyna, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2005
Melanin photoprotection in the human retinal pigment epithelium and its correlation with light-induced cell apoptosisBrandon-Luke L Seagle, Kourous A Rezai, Yasuhiro Kobori, et al.
Connecticut Medicine|September 9, 2014
Genetic counseling for hereditary breast and gynecologic cancer syndromes at a community hospitalKarina M Haber, Brandon-Luke L Seagle, Barbara Drew, et al.
Scientific Reports|February 18, 2016
Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancerBrandon-Luke L Seagle, Kevin H Eng, Judy Y Yeh, et al.
Gynecologic Oncology|January 21, 2019
Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancerChelain R Goodman, Saleh Hatoum, Brandon-Luke L Seagle, et al.
Gynecologic Oncology|May 11, 2015
TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome AtlasBrandon-Luke L Seagle, Chia-Ping Huang Yang, Kevin H Eng, et al.
Pageof 5